Metastasis is the ultimate stage of tumor progression and is the major cause of morbidity and mortality in cancer patients. The central theme of this research proposal is to investigate whether this process can be modulated and ultimately suppressed. Matrix metalloproteinases (MMPs) a family of endopeptidases with proteolytic activity for several essential constituents of the extracellular matrix (ECM) are secreted in abundance by metastatic tumor cells enabling them to invade surrounding tissues and to metastasize. We hypothesize that during invasion, the homeostatic balance between these enzymes and their corresponding activators and inhibitors is perturbed toward excess proteolysis and degradation of the ECM. We propose to modify this perturbed balance using a specific and novel metalloproteinase inhibitor designated metalloproteinase inhibitor/tissue inhibitor of metalloproteinase-2 (MI/TIMP-2) recently isolated in our laboratory. Biological and regulatory aspects of this inhibitor will be examined. We will change the enzyme-inhibitor balance in metastatic tumor cells toward excess inhibition using recombinant human MI/TIMP-2 and by transfecting these cells with MI/TIMP-2 cDNA in mammalian expression vectors. Experiments win also be performed with recombinant inhibitors of plasminogen activator (PAls) and PAI's cDNA used in combination with MI/TIMP-2 to examine the effect of the additional inhibition of another proteolytic cascade. The effect of these changes on the proteolytic activity and on the invasive and metastatic potentials of these cells will be analyzed. Experiments on regulatory aspects of MI/TIMP-2 will investigate whether this inhibitor is similarly regulated in normal cells and tumor cells and whether its regulation is independent from TIMP. These studies will determine whether invasion and metastasis are processes that can be controlled if the normal homeostasis between tumor cells and their surrounding tissue is restored. Our knowledge of regulatory mechanisms that control this homeostasis could then be used to prevent or suppress tumor invasion and metastasis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA042919-04A2
Application #
3184629
Study Section
Pathology B Study Section (PTHB)
Project Start
1987-05-01
Project End
1994-06-30
Budget Start
1991-07-01
Budget End
1992-06-30
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Children's Hospital of Los Angeles
Department
Type
DUNS #
094878337
City
Los Angeles
State
CA
Country
United States
Zip Code
90027
Blavier, Laurence; Lazaryev, Alisa; Shi, Xiang-He et al. (2010) Stromelysin-1 (MMP-3) is a target and a regulator of Wnt1-induced epithelial-mesenchymal transition (EMT). Cancer Biol Ther 10:198-208
Wall, Steven J; Zhong, Zhi-Duan; DeClerck, Yves A (2007) The cyclin-dependent kinase inhibitors p15INK4B and p21CIP1 are critical regulators of fibrillar collagen-induced tumor cell cycle arrest. J Biol Chem 282:24471-6
Jodele, Sonata; Blavier, Laurence; Yoon, Janet M et al. (2006) Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev 25:35-43
Wall, Steven J; Werner, Erica; Werb, Zena et al. (2005) Discoidin domain receptor 2 mediates tumor cell cycle arrest induced by fibrillar collagen. J Biol Chem 280:40187-94
Wall, Steven J; Jiang, Yong; Muschel, Ruth J et al. (2003) Meeting report: Proteases, extracellular matrix, and cancer: an AACR Special Conference in Cancer Research. Cancer Res 63:4750-5
Blavier, L; Lazaryev, A; Groffen, J et al. (2001) TGF-beta3-induced palatogenesis requires matrix metalloproteinases. Mol Biol Cell 12:1457-66
Zhong, Z D; Hammani, K; Bae, W S et al. (2000) NF-Y and Sp1 cooperate for the transcriptional activation and cAMP response of human tissue inhibitor of metalloproteinases-2. J Biol Chem 275:18602-10
DeClerck, Y A (2000) Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. Eur J Cancer 36:1258-68
Henriet, P; Zhong, Z D; Brooks, P C et al. (2000) Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1. Proc Natl Acad Sci U S A 97:10026-31
Blavier, L; Henriet, P; Imren, S et al. (1999) Tissue inhibitors of matrix metalloproteinases in cancer. Ann N Y Acad Sci 878:108-19

Showing the most recent 10 out of 42 publications